上交所新增受理核心医疗科创板上市申请

Core Points - Shenzhen Core Medical Technology Co., Ltd. has submitted its application for listing on the Sci-Tech Innovation Board, aiming to raise 1.217 billion yuan [1] - The company, established in August 2016, focuses on providing comprehensive, innovative, and high-quality artificial heart products [1] - Huatai United Securities Co., Ltd. is the sponsor for this issuance [1] Financial Performance - The company's projected revenues for 2022, 2023, and 2024 are 0 million yuan, 16.55 million yuan, and 93.6884 million yuan, respectively, indicating a significant growth of 466.08% in 2024 [1] - Net profits for the same years are projected at -178 million yuan, -170 million yuan, and -132 million yuan, showing a year-on-year improvement of 22.44% in 2024 [1] - Key financial metrics for 2024 include a basic and diluted earnings per share of -0.44 yuan, and a weighted average return on equity of -38.08% [1]